Evidence map›Paper›PMID 41229569›Full record

ArticleTherapeutic advances in infectious disease

Impact of a multistep urinary tract infection-focused disease state stewardship initiative on the treatment of asymptomatic urinary presentations: a retrospective cohort study.

Christian Tyler Pitcock, Danielle Casaus, Sarah E Garvey, Katie Ruf, Donna R Burgess, Jeremy D VanHoose, David S Burgess, Ryan Mynatt, Armaghan-E-Rehman Mansoor, Nicholas Van Sickels and 4 more

Abstract read
In one paragraph

Article in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Christian Tyler PitcockDepartment of Pharmacy, Duke University Hospital, Durham, NC, USA.ORCID https://orcid.org/0009-0005-3596-1607
Danielle CasausDepartment of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY, USA.
Sarah E GarveyDepartment of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY, USA.
Katie RufDepartment of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY, USA.
Donna R BurgessDepartment of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY, USA.
Jeremy D VanHooseDepartment of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY, USA.ORCID https://orcid.org/0009-0008-3280-0789
David S BurgessDepartment of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, KY, USA.
Ryan MynattDepartment of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY, USA.
Armaghan-E-Rehman MansoorDivision of Infectious Diseases, Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.ORCID https://orcid.org/0000-0002-2087-187X
Nicholas Van SickelsDivision of Infectious Diseases, Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.ORCID https://orcid.org/0009-0000-1435-0720
Mitu Karki MaskeyDivision of Infectious Diseases, Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.
Thein MyintDivision of Infectious Diseases, Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.
Aric SchadlerDepartment of Statistics, University of Kentucky College of Pharmacy, Lexington, KY, USA.
Katie L WallaceDepartment of Pharmacy Services, University of Kentucky HealthCare, 800 Rose Street, Lexington, KY, USA.ORCID https://orcid.org/0000-0002-9718-8067

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Asymptomatic bacteriuria (ASB) is often overtreated, risking patient harm through unnecessary antimicrobial use and fostering antimicrobial resistance. Despite this, patients continue to be treated for ASB requiring targeted intervention for antimicrobial stewardship teams across health systems. Objectives: This study assessed the impact of a multistep urinary tract infection (UTI)-focused stewardship initiative by comparing the incidence of asymptomatic urinary presentation (AUP) treatment before and after implementation. Design: Retrospective cohort study. Methods: Patients ⩾18 years at University of Kentucky HealthCare who received antimicrobial therapy with a urinalysis (UA) and/or urine culture (UCx) collected for a presumed UTI between January 2023 and March 2023 (pre-implementation) and January 2024 and March 2024 (post-implementation) were included in the study. Our primary outcome was to compare the frequency of AUP treatment between groups. Results: Overall, 288 patients were included in the study, with 144 patients in both the pre- and post-implementation groups. Treatment of AUPs significantly decreased by 12% after initiative implementation (47% pre-implementation vs 35% post-implementation, Conclusion: Our stewardship initiative resulted in reduced treatment of AUPs and improved adherence to UTI management guidelines. Overall, a multifaceted stewardship initiative is a successful intervention to decrease the treatment of AUPs and unnecessary antibiotic utilization. However, additional frontline stewardship initiatives are likely warranted to decrease the unnecessary ordering of UAs.

Indexed as

antimicrobial stewardshipasymptomatic bacteriuriaUTI

Identifiers

PMID41229569
PMCPMC12602917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.